RBC Bioscience

RBC Bioscience Accounts Payable

The Accounts Payable of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 23.77 M TWD. In the previous year, Accounts Payable was 15.72 M TWD — a change of 51.21% (higher).

Accounts Payable

23.77 MTWD

YoY

51.21%

Last updated:

Accounts Payable of RBC Bioscience is 2024 23.77 M TWD. Accounts Payable of RBC Bioscience was 2023 15.72 M TWD. It decreases by 51.21% higher compared to the previous year.

The RBC Bioscience Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
15.36 M TWD
Jan 1, 2019
16.58 M TWD
Jan 1, 2020
101.06 M TWD
Jan 1, 2021
35.75 M TWD
Jan 1, 2022
22.71 M TWD
Jan 1, 2023
15.72 M TWD
Jan 1, 2024
23.77 M TWD
The RBC Bioscience Accounts Payable history
YEARAccounts PayableYoY
23.77 MTWD+51.21%
15.72 MTWD-30.78%
22.71 MTWD-36.48%
35.75 MTWD-64.63%
101.06 MTWD+509.54%
16.58 MTWD+7.97%
15.36 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Accounts Payable of RBC Bioscience is 23.77 M TWD in 2024.

Accounts Payable of RBC Bioscience changed from 15.72 M TWD to 23.77 M TWD, representing a 51.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RBC Bioscience

All Key Metrics — RBC Bioscience